Scinovex
article Open AccessTop 1% cited

Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid

Neuroscience Letters · 1992 · Vol. 135(2) · pp. 235–238
Thomas WısnıewskıBlas Frangione

Abstract

Many biochemically diverse proteins can give rise to amyloid fibrils; however, they are all accompanied by P component and glucosaminoglycans. With antibodies specific to apolipoprotein E (apo E) we used immunohistochemical techniques to test for the presence of this protein in both cerebral and systemic amyloid. We found apo E immunoreactivity in all tested types of cerebral and systemic amyloid. In amyloid deposits apo E P, component and glucosaminoglycans may be acting as 'pathological molecular chaperones'. The latter we define as a group of unrelated proteins that induce beta-pleated conformation in amyloidogenic polypeptides.

Amyloidosis: Diagnosis, Treatment, OutcomesAlzheimer's disease research and treatmentsBioinformatics and Genomic NetworksAmyloid (mycology)PathologicalApolipoprotein EImmunohistochemistrySerum amyloid P componentApolipoprotein BAmyloidosisBiochemistry of Alzheimer's diseaseAmyloid fibrilP3 peptide

MeSH terms

AmyloidSerum Amyloid P-ComponentApolipoproteins EBrain ChemistryGlycosaminoglycansHumansNervous System DiseasesMicroscopy, ImmunoelectronParaffin Embedding
Citations
800
FWCI
23.52
field-weighted impact
References
25
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.